Company intelligence / Profile preview

RH Bioprocess Consulting

Ownership: Private
Development stage: Other

Overview

RH Bioprocess Consulting provides strategic and technical consulting services for biopharmaceutical production and technology development. They support process development, manufacturing strategy, CMO evaluation/selection, facility design/planning, due diligence for M&A/investment decisions, and have expertise in complex biologics including live viral vectors for gene therapy and vaccines. No clinical results as they do not sponsor trials.

Modalities: Therapeutic proteinCell therapyGene therapymRNA-based drugsRecombinant proteinOncolytic virus therapyVaccineProtein (general)
Industry: Consulting

Partnerships

Collaborates with a network of industry experts in the US, Europe and Asia for project delivery.

Beyond the preview

Go deeper on RH Bioprocess Consulting.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RH Bioprocess Consulting.

Explore the full profile